Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19:5:1492369.
doi: 10.3389/fdmed.2024.1492369. eCollection 2024.

Stannous fluoride protects gingival keratinocytes against infection and oxidative stress by Porphyromonas gingivalis outer membrane vesicles

Affiliations

Stannous fluoride protects gingival keratinocytes against infection and oxidative stress by Porphyromonas gingivalis outer membrane vesicles

Sancai Xie et al. Front Dent Med. .

Abstract

Objective: To determine whether outer membrane vesicles (OMVs) of the periodontal pathogen Porphyromonas gingivalis (P. gingivalis) can infect gingival keratinocytes and stimulate reactive oxygen species (ROS) production, and to assess whether stannous fluoride (SnF2), stannous chloride (SnCl2) or 0.454% SnF2 toothpaste diluents can inhibit OMV infection.

Methods: OMVs were isolated from P. gingivalis culture and their morphology was characterized using scanning electron microscopy and transmission electron microscopy. OMVs were harvested, separated from parent bacteria, labeled with fluorescent probes, and added to proliferating gingival keratinocytes. Infection was monitored by measuring uptake of fluorescence. Free radicals and ROS were quantified by adding a separate CellROX fluorescent probe following 24 h incubation with OMVs, and automated fluorescence imaging was used to assess ROS generation rates. A dose response range of SnF2 and SnCl2 concentrations as well as 0.454% SnF2 toothpaste dilutions were added to OMVs to examine their potential to neutralize OMV infectivity and protect gingival keratinocytes from development of oxidative stress. The mechanism of SnF2 inhibition of OMV infection was studied by binding SnF2 with purified lipopolysaccharides (LPS) from the bacterial culture and examining the binding of stannous to LPS using mass spectrometry.

Results: Large numbers of OMVs were formed in P. gingivalis culture medium. They were purified along with isolating soluble LPS. Fluorescence imaging revealed that OMVs infected gingival keratinocytes and promoted oxidative stress in a dose-dependent manner. SnF2, SnCl2, and SnF2 toothpaste inhibited OMV infectivity (p < 0.05) and likewise protected gingival keratinocytes from oxidative stress (p < 0.05). Stannous precipitated LPS and OMVs from solution, forming insoluble aggregates easily isolated by centrifugation. Mass spectroscopic analysis revealed that stannous was bound to LPS in a one-to-one molecular equivalent ratio.

Conclusion: SnF2 not only kills bacteria, but also inhibits bacterial virulence factors, such as LPS and OMVs. SnF2, SnCl2 and stannous-containing toothpastes can precipitate OMVs and LPS to in principle protect gingival keratinocyte cells from infection leading to inflammation and oxidative stress.

Keywords: Porphyromonas gingivalis; antibacterial agents; keratinocyte infection; periodontal diseases; reactive oxygen species; scanning electron microscopy; stannous fluoride; transmission electron microscopy.

PubMed Disclaimer

Conflict of interest statement

All authors are employees of The Procter & Gamble Company, a manufacturer of SnF2 dentifrice.

Figures

Figure 1
Figure 1
Isolation and characterization of P. gingivalis OMVs. (A) SEM of P. gingivalis bacteria with small outgrowths on surface. (B) Several OMVs (yellow arrow) adjacent to a P. gingivalis bacterium (blue arrow). (C) P. gingivalis OMVs in the culture medium. (D) A visible band of OMVs in OptiPrep gradient gel. (E,F) Purified OMVs of P. gingivalis.
Figure 2
Figure 2
SnF2 and SnCl2 inhibited OMV entry into gingival keratinocytes. (A) Images of fluorescent-labeled OMVs (green) entry into gingival keratinocytes. (B) Entry of OMVs into gingival keratinocytes in a dose curve. Each time point represented the mean and SE of three separate experiments. (C) SnF2 and (D) SnCl2 inhibited entry of OMVs into gingival keratinocytes at 42 h. Each bar represented the mean and SE of three separate experiments. The plots were generated using ggpubr package in RStudio. The results were analyzed using one-way ANOVA and t-test conducted to compare the difference with OMV alone (stannous is 0 μM) as the reference group in stat_compare_means of Rstudio packages.
Figure 3
Figure 3
Effects of P. gingivalis OMVs on oxidation of CellROX dyes in gingival keratinocytes. (A) Images of OMV (red) infection and oxidation of CellROX (green). (B) Entry of OMVs into gingival keratinocytes. (C) Oxidation of CellROX dyes in gingival keratinocytes. (D) Cell confluence evaluated by phase contract images. Each time point represented the mean and SE of five separate experiments.
Figure 4
Figure 4
Effects of SnF2 and SnCl2 on the intake of fluorescence-labeled OMV (Red) and oxidized CellROX Dye (green): (A) Images of OMV intake and oxidized CellROX green in cells infected with 0.65 μg/ml OMVs without or with SnF2 or with SnCl2. (B) SnF2 and (C) SnCl2 inhibited cellular oxidation of CellROX. Each point represents the mean and SE from four separate experiments at 42 h. CellROX fluorescence was expressed as relative fluorescence. P-values listed here were from pairwise comparisons with the stannous 0 µM (OMV at 0.65 µg/ml alone) as the reference group.
Figure 5
Figure 5
Effects of stannous-based toothpastes on OMV entry and oxidative stress. (A) Images showing OMV (red) entry into gingival keratinocytes and oxidized CellROX Green stains (green). (B) Entry of fluorescence-labeled OMVs into gingival keratinocytes. (C) Quantification of oxidized CellROX dyes inside the cells. CellROX fluorescence and OMV fluorescence are presented as relative fluorescence. Results from two SnF2-containing toothpastes were pooled for analysis. Each bar represents the mean and SE of four separate experiments.
Figure 6
Figure 6
OMVs of P. gingivalis and SnF2 formed precipitates. (A) SnF2 binds OMVs and forms precipitates. (B) Time course of stannous binding to OMVs. Each time point represents the mean and SE of 24 independent measurements. 0 mM SnF2 was not represented in B since the OD600 was 0. Relative OD600 values were obtained by dividing OD600 by the average OD600 of the 2 µg/ml OMV + 1 mM SnF2 samples at the 60 min timepoint. Mixed effect models were fitted to the relative OD600, and all comparisons were significant at 0.01 after Bonferroni adjustment. These comparisons include SnF2 + OMV vs. SnF2, OMV + 0.5 mM SnF2 vs. OMV, and OMV + 1 mM SnF2 vs. OMV.
Figure 7
Figure 7
Mass spectrum analysis of stannous and LPS binding. P. gingivalis LPS is highly heterogeneous in size and structure. Each peak represents one molecule of LPS. There were two groups of LPS peaks in the LPS alone panel as indicated by the red circles. With SnF2, two more groups of peaks were generated as represented by the blue circles. The peaks in the blue circles were shifted by 116, 118 or 120 da to the right as indicated by the green arrows.
Figure 8
Figure 8
SnF2 interacts with OMVs to form aggregates. (1). OMVs are highly effective in entering gingival keratinocytes. (2). LPS on the surface of OMVs can interact with stannous, which is bivalent. Stannous can bind two OMV structures or bind one OMV and another stannous. (3). As more OMVs are linked together, they form a large aggregate. (4). Large aggregates of OMVs reduce the effective concentration of OMVs in the solution, and retard entry into gingival keratinocytes.
Figure 9
Figure 9
Proposed model for relationship between OMV infection and systemic exposure. (A) P. gingivalis within plaque in the gingival sulcus produces OMVs. (B) OMVs adhere to gingival keratinocytes, leading to invasion of keratinocytes. (C) OMVs can migrate through the disrupted epithelial barrier and into the underlying capillary beds creating a potential pathway to introduce OMVs into the circulatory system where they could be carried to distant tissues and organs, including the brain, liver and heart.

References

    1. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci. (2017) 11(2):72–80. - PMC - PubMed
    1. Nazir M, Al-Ansari A, Al-Khalifa K, Alhareky M, Gaffar B, Almas K. Global prevalence of periodontal disease and lack of its surveillance. Sci World J. (2020) 2020:2146160. 10.1155/2020/2146160 - DOI - PMC - PubMed
    1. Page RC. Gingivitis. J Clin Periodontol. (1986) 13(5):345–59. 10.1111/j.1600-051x.1986.tb01471.x - DOI - PubMed
    1. Bamashmous S, Kotsakis GA, Kerns KA, Leroux BG, Zenobia C, Chen D, et al. Human variation in gingival inflammation. Proc Natl Acad Sci U S A. (2021) 118(27):e2012578118. 10.1073/pnas.2012578118 - DOI - PMC - PubMed
    1. Slots J. Periodontitis: facts, fallacies and the future. Periodontol 2000. (2017) 75(1):7–23. 10.1111/prd.12221 - DOI - PubMed